Nao Fujimori

Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial

Kohei Nakachi, Masafumi Ikeda, Masaru Konishi et al. · The Lancet · 2023 · 214 citations

Surgical Oncology, Gastrointestinal Oncology, Medicine +9

JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis

Tetsuhide Ito, Toshihiko Masui, Izumi Komoto et al. · Journal of Gastroenterology · 2021 · 151 citations · Full text

Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity

Junya Gibo, Tetsuhide Ito, Ken Kawabe et al. · Laboratory Investigation · 2004 · 115 citations · Full text

Inflammation, Fibrosis, Signal Transduction +9

Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors

Nao Fujimori, Takashi Osoegawa, Lingaku Lee et al. · Scandinavian Journal of Gastroenterology · 2015 · 95 citations

Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer Potentially Improves Survival and Facilitates Surgery

Yoshihiro Miyasaka, Takao Ohtsuka, Ryuichiro Kimura et al. · Annals of Surgical Oncology · 2019 · 90 citations

Surgical Oncology, Oncology, Pancreatic Cancer +9